Skip to main content

Increased Basal Transepidermal Water Loss

There are indications of elevation of some inflammatory serine proteases in barrier damaged skin (e.g. plasmin and urokinase). Moreover, many other serine protease activities are present such as desquamatory enzymes as well as a newly detected tryptase-like serine protease.

However, the activities of these proteases have never been correlated with stratum corneum (SC) barrier function. The activity of extractable key serine proteases (SC trypsin-like kallikreins, SC chymotrypsin-like kallikreins, SC tryptase-like serine protease, urokinase and plasmin) was measured from the outermost layers of SC obtained from facial tape strippings in clinically normal subjects.

The protein content of the tape strippings was quantified by absorption measurements with the novel infrared densitometer SquameScan 850A and the protease activities by the use of fluorogenic peptide substrates. SC barrier function, SC hydration and skin surface pH were measured using AquaFlux, NOVA dermal phase meter and Skin-pH-Meter, respectively.

As expected, SC hydration was reduced with increased transepidermal water loss (TEWL) values indicative of barrier impairment. Surprisingly, SC chymotrypsin-like activity showed no correlation with hydration or TEWL, whereas all other enzymes positively correlated with impaired barrier function and some were statistically significant: SC trypsin-like kallikreins (R(2 )=0.66, P psoriasis and rosacea but these results indicate that these enzymes are also elevated with milder forms of barrier disruption, which is not clinically evident as irritated skin.

As these proteases are elevated in the SC, they will also be elevated in the epidermis where they can be involved in neurogenic inflammation and epidermal barrier impairment via activation of the protease-activated receptors.

These results highlight the need for using serine protease inhibitors especially for urokinase and plasmin, SC tryptase-like serine protease and possibly SC trypsin-like kallikreins even in milder forms of barrier damage.


Increased basal transepidermal water loss leads to elevation of some but not all stratum corneum serine proteases"
Voegeli R, Rawlings AV, Doppler S, Schreier T
Int J Cosmet Sci. 2008 Dec ; 30(6): 435-42 (Hubmed.org)




Highlight :
Treatment Of Rosacea | Acne Rosacea Antibiotic | Acne Rosacea | Rosacea Creams

Popular posts from this blog

1971 Innocenti Mini Cooper

1971 Innocenti Mini Cooper " An original Austin Mini Cooper. Not that strange, except I'm 6'4" and 260lbs. Would look kinda funny gettin in and out. _____ " Search Suggestion mk1forum net ̢ۢ view topic early navy blue 1275 gt seats Austin Cooper 998 Mk II 1969 Austin Mini Clubman 1970 Morris Mini Clubman 1275 GT 1971 Cooper S mk III replica 1971 Innocenti Cooper 1300 Export 1974 Morris mini 850 1976. http://mk1-forum.net/viewtopic.php?f=8&t=116 innocenti mini cooper flickr photo sharing After 1971 the production of Mini Coopers were continued in license in Italy by Innocenti as the Innocenti Mini Cooper 1300 and in Spain by Authi (Automoviles de Turismo Hispano . http://www.flickr.com/photos/ilmungo/26099568/ austin mini coopers for sale austin mini cooper classifieds In 1971, the 1275 cc Mini Cooper S was discontinued in the UK, leaving the Mini 1275GT as the only sporting Mini on sale for the rest of the decade. Innocenti in Italy . ht...

Azelaic acid in the treatment of papulopustular rosacea

To evaluate the clinical efficacy of topical 20% azelaic acid cream and 15% azelaic acid gel compared with their respective vehicles and metronidazole gel in the treatment of papulopustular rosacea . DATA SOURCES: Electronic searches of MEDLINE, EMBASE, BIOSIS, and SciSearch through July or August 2004 and the Cochrane Central Register of Controlled Trials through 2004 (issue 3). We performed hand searches of reference lists, conference proceedings, and clinical trial databases. Experts in rosacea and azelaic acid were contacted. STUDY SELECTION: Randomized controlled trials involving topical azelaic acid (cream or gel) for the treatment of rosacea compared with placebo or other topical treatments. Two authors independently examined the studies identified by the searches. Ten studies were identified, of which 5 were included (873 patients). DATA EXTRACTION: Two authors independently extracted data from the included studies, then jointly assessed methodological quality using a quality a...

Management of benign skin lesions commonly affecting the face: actinic keratosis, seborrheic keratosis, and rosacea.

Curr Opin Otolaryngol Head Neck Surg. 2009 May 21; Brodsky JPURPOSE OF REVIEW: Patients commonly present to the otolaryngologist for management of benign facial lesions. It is important to be able to both recognize these lesions and offer patients the most effective therapies currently available. Advances in the understanding and management of three of the more common benign skin lesions affecting the face will be addressed in this review, with a particular emphasis on the most current therapeutic options for each lesion. RECENT FINDINGS: Actinic keratosis can now be treated with photodynamic therapy or with many topical agents, as alternatives to traditional surgical techniques. Seborrheic keratosis, as well as actinic keratosis and rosacea, are now often treated with laser therapy. In addition, rosacea management now includes nonantimicrobial topical agents, such as azelaic acid, and a wider armamentarium of systemic agents. SUMMARY: An understanding of these options will allow the ...